(Q43621931)

25 November 2017

title

Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

17 October 2022

author name string

Z. Agur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1627380

17 October 2022

R. Arnon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1627380

17 October 2022

B. Schechter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1627380

17 October 2022

language of work or name

1 reference

1 January 1992

1 reference

full work available at URL

25 November 2017

https://api.elsevier.com/content/article/PII:095980499290463C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

https://api.elsevier.com/content/article/PII:095980499290463C?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

European Journal of Cancer

17 October 2022

published in

1 reference

25 November 2017

volume

28A

1 reference

25 November 2017

issue

6-7

1 reference

25 November 2017

page(s)

1085-1090

1 reference

Are cell kinetic data relevant for the design of tumour chemotherapy schedules?

25 November 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Studies on the persistence of methotrexate, cytosine arabinoside, and leucovorin in serum of mice

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Cytotoxic reduction and regeneration of murine marrow stem cells

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Study on the long-term toxic efficacy of cytosine-arabinoside in Sprague-Dawley rats

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Investigations of a stochastic model of haemopoiesis

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Cell kinetic behaviour of a synchronized population of erythroid precursor cells in vitro

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Increased Tolerance of Leukemic Mice to Arabinosyl Cytosine with Schedule Adjusted to Circadian System

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

Pluripotent haemopoietic stem cell entry into DNA synthesis in vitro after stimulation by Ara-C treatment in vivo

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90463-C

17 October 2022

Identifiers

1 reference

25 November 2017

1 reference